Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Total revenue $ 6,909 $ 5,447 $ 11,050 $ 12,455
Operating expenses:        
Research and development 30,414 10,243 51,045 18,697
General and administrative 6,412 4,605 12,059 9,540
Total operating expenses 36,826 14,848 63,104 28,237
Loss from operations 29,917 9,401 52,054 15,782
Interest and other income, net 286 543 758 1,053
Interest and other expense, net (360) (301) (708) (594)
Loss on extinguishment of debt (1,237) 0 (1,237) 0
Change in fair value of warrant liabilities 0 6 0 2
Loss before provision for income taxes 31,228 9,153 53,241 15,321
Provision for income taxes 0 0 5 0
Net loss 31,228 9,153 53,246 15,321
Net loss attributable to common shareholders $ 31,228 $ 9,153 $ 53,246 $ 15,321
Net loss per share attributable to common shareholders:        
Basic and diluted $ 0.68 $ 0.25 $ 1.17 $ 0.42
Weighted average number of shares used in net loss per share calculations:        
Basic and diluted 45,725,481 36,819,846 45,687,278 36,779,638
Research And Development Revenue | Other        
Total revenue $ 2,977 $ 0 $ 4,444 $ 0
Research And Development Revenue | Related Party        
Total revenue 3,063 5,211 3,396 11,624
Grant        
Total revenue $ 869 $ 236 $ 3,210 $ 831